Foley, Peter A

• SKIN The Journal of Cutaneous Medicine Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas - Hidradenitis Suppurativa
  Adalimumab Efficacy in Hidradenitis Suppurativa Patients is Sustained at Least Three Years with Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER)
  Abstract  Poster PDF